Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Feb 2018 for Sucampo Pharmaceuticals, Inc., €89k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Alex Driggs: trading record in brief
Alex Driggs discloses dealings in Sucampo Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 30 June 2017 to 13 February 2018, the count stands at 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 13 February 2018, the filings show a transaction worth €89k in Sucampo Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alex Driggs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
6,084 shares@ US$18.0065.9% of flowCommon Stock, Class ASEC:0001171843-18-001099:0
660 shares@ US$9.103.7% of flowCommon Stock, Class A (ESPP)SEC:0001171843-18-000176:0
2,025 shares@ US$17.9822.7% of flowCommon Stock, Class ASEC:0001171843-18-000047:0
659 shares@ US$9.103.8% of flowCommon Stock, Class A (ESPP)SEC:0001171843-17-005957:0
672 shares@ US$8.933.9% of flowCommon Stock, Class A (ESPP)SEC:0001171843-17-004001:0
5 of 5 declarations
